Categories Article Boron Compounds Chemistry In-vitro Studies In-vivo Studies Radiobiology Year 2020 Sunitinib containing carborane pharmacophore with ability to inhibit tyrosine kinases receptors, FLT3, KIT, and PDGFR-β, exhibits powerful in vivo anti-glioblastoma activity Post author By ISNCT Post date September 27, 2022 Cancers, 2020 Tags B. Dávila, C. Alamón, C. Sánche, C. Viñas, Cancers, E. Trias, F. Teixidor, L. Barbeito, M. Couto and H. Cerecetto, M. Gabay, M. Gavish, M. Kovacs, M.F. García, N. Zeineh
ISNCT